Martin L. Moore

Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses

Jeong-Joong Yoon, Märt Toots, Sujin Lee et al. · Antimicrobial Agents and Chemotherapy · 2018 · 245 citations · Full text

Medicine, Infectious Diseases, Pharmacology +16

Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma

Nandini Krishnamoorthy, Anupriya Khare, Timothy B. Oriss et al. · Nature Medicine · 2012 · 234 citations · Full text

Life Sciences, Immunology, Infectious Diseases +12

Respiratory syncytial virus infection activates IL-13–producing group 2 innate lymphoid cells through thymic stromal lymphopoietin

Matthew T. Stier, Melissa H. Bloodworth, Shinji Toki et al. · Journal of Allergy and Clinical Immunology · 2016 · 189 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Differential Pathogenesis of Respiratory Syncytial Virus Clinical Isolates in BALB/c Mice

Kate L. Stokes, Kaori Sakamoto, Dawn C. Newcomb et al. · Journal of Virology · 2011 · 187 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

A Chimeric A2 Strain of Respiratory Syncytial Virus (RSV) with the Fusion Protein of RSV Strain Line 19 Exhibits Enhanced Viral Load, Mucus, and Airway Dysfunction

Martin L. Moore, H. Michael, Cindy Luongo et al. · Journal of Virology · 2009 · 168 citations

Life Sciences, Infectious Diseases, Molecular Biology +17